Neil F. McFarlane
2019
In 2019, Neil F. McFarlane earned a total compensation of $2.1M as Chief Executive Officer at Adamas Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $125,200 |
|---|---|
| Option Awards | $957,325 |
| Salary | $182,292 |
| Stock Awards | $781,250 |
| Other | $34,575 |
| Total | $2,080,642 |
McFarlane received $957.3K in option awards, accounting for 46% of the total pay in 2019.
McFarlane also received $125.2K in non-equity incentive plan, $182.3K in salary, $781.3K in stock awards and $34.6K in other compensation.
Rankings
In 2019, Neil F. McFarlane's compensation ranked 5,726th out of 13,971 executives tracked by ExecPay. In other words, McFarlane earned more than 59.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,726 out of 13,971 | 59th |
Division Manufacturing | 2,145 out of 5,695 | 62nd |
Major group Chemicals And Allied Products | 773 out of 2,194 | 65th |
Industry group Drugs | 650 out of 1,880 | 65th |
Industry Pharmaceutical Preparations | 477 out of 1,392 | 66th |
Source: SEC filing on April 23, 2020.
McFarlane's colleagues
We found three more compensation records of executives who worked with Neil F. McFarlane at Adamas Pharmaceuticals in 2019.